Samsung announced their image post-processing engine (IPE), dubbed S-Vue 3.02, recently received FDA clearance. The device employs a noise-reduction algorithm that allows devices to produce the same high-quality image using less radiation in pediatric patients.
In total, the image evaluations on devices using S-Vue reduced the Xray dose up to 45 percent in pediatric abdomen exams, 15.5 percent for pediatric chest exams, and up to 27 percent for pediatric skull exams. This data was compared with the previous IPE using the same Xray systems.
“Findings of our clinical trial showed that use of Samsung’s S-Vue for pediatric chest images resulted in an overall image quality that was uncompromised even at a significantly reduced radiation exposure,” said Susan John, MD, professor and chair, Diagnostic and Interventional Imaging at McGovern Medical School at The University of Texas Health Science Center at Houston (UT Health). “The reduction in radiation dose potentially enables repeat radiographs for better follow-up in patients from infancy into adulthood, while assisting us in confident diagnosis.”
Attempting to lower Xray exposure is a constant concern for many healthcare professionals. Samsung hopes by lowering the dose exposure in Xray systems they can push new preventative measures in the healthcare sector.
“Constantly working to lower dose exposure is a top priority for radiologists and healthcare professionals, and Samsung’s ability to offer dose reduction across its suite of DR machines represents another breakthrough in medical imaging technology. This new low-dose protocol is proof that we’re continuing to reduce radiation dose in our products. We are delighted that we are now able to offer this to the patients who are most vulnerable,” David Legg, vice president, Head of Ultrasound and Digital Radiography Business at NeuroLogica, the healthcare subsidiary of Samsung Electronics, said.
